← Back to Mar 2014

links imageIN THE SPOTLIGHT:

ISHLT 2014 in Sunsational San Diego!

Featuring Meeting Highlights in Pulmonary Hypertension and Pediatric Transplantation

At ISHLT 2014, there will be a number of symposia with primary content of interest in pulmonary hypertension as well as pediatric transplantation. Find out which sessions will be of most interest to you, and plan your trip to San Diego TODAY!

Focus on Pulmonary Hypertension:

We are very pleased to present an outstanding program at ISHLT 2014 that covers a diverse range of innovations and controversial topics in Pulmonary Hypertension. There are four Pre-Meeting Symposia, three Sunrise Sessions, and one Concurrent session that will highlight the latest clinical consensus statements, discuss the emerging sciences, and pose questions to the experts and audiences for discussion and feedback. These sessions will be of keen interest to all members of ISHLT engaged in the care of patients with cardiopulmonary disease and right heart failure.

PRE-MEETING SYMPOSIUM 2: Pulmonary Hypertension: You Can't Ignore It any Longer (Thursday, April 12, 8:00 AM - 10:00 AM)
To kick off the meeting, this session will tackle the controversial area of managing patients with lung disease and pulmonary hypertension, WHO Group III, focusing on patients with ILD, COPD and sarcoidosis.

PRE-MEETING SYMPOSIUM 8: CTEPH: Busting the Clot (Thursday, April 12, 10:15 AM - 12:15 PM)
What better place to focus on all the latest exciting developments in chronic thromboembolic pulmonary hypertension (CTEPH) than San Diego! This session features both medical and surgical aspects in managing CTEPH patients with presentations highlighting the emerging new treatment, riociguat, as well as a debate to consider exercise-induced PH as an indication for pulmonary thromboendarterectomy.

PRE-MEETING SYMPOSIUM 14: Treating All Stages of Severe PH: Are We Doing it Right? (Thursday, April 12, 2:00 PM - 4:00 PM)
This session will discuss the emerging basic sciences focusing on mechanisms and management approaches for patients with severe PH and right heart failure, from pulmonary vasodilators to mechanical supports. links imageWe are also very excited to present to you the ISHLT and World Symposium on PH (WSPH) Consensus Initiative on PH and Left Heart Disease in Pre-Meeting Symposium 20, which will present discussions asking what are the important hemodynamic variables in those with advanced heart failure and PH?

CONCURRENT SYMPOSIUM 25: A Lifecycle Journey in Pulmonary Hypertension (Friday, April 11, 10:30 AM - 12:00 PM)
This session will present the lifecycle journey of a patient facing PAH, focusing on clinical milestones and challenges that face these patients from diagnosis to advanced stages of disease.

SUNRISE SYMPOSIUM 2: Under Too Much Pressure (Friday, April 11, 7:00 AM - 8:00 AM)
This is meant to be a multidisciplinary symposium (cardiology, pulmonary, PH) discussing management of challenging patients who have complicating pulmonary hypertension. Three cases will be presented by junior faculty members. The case presentations will include challenges to the discussants (in an open forum) regarding next steps in evaluation, management, etc of pulmonary hypertension.

SUNRISE SYMPOSIUM 7: The Effects of Prostaglandin Therapy in PAH: The Seen and Unseen Risk/Benefit Profile (Saturday, April 12, 7:00 AM - 8:00 AM)
This session explores all the effects, both seen and unseen, in patients associated with parenteral prostanoid treatments. We are also very pleased to bring you a "How To" session, featuring oft asked questions regarding PA catheters in our Sunrise Symposium 12. You will get to engage in discussions regarding how to do volume loading, when to use vasodilator testing, and how to utilize exercise RHC and what the results mean.


CLOSING PLENARY (Sunday, April 13, 9:30 AM - 11:45 AM)
The grand finale, during the Closing Plenary session, will feature a debate you don't want to miss: Stop Treating Secondary PH Right Now! See which side you will vote for! We look forward to seeing you all in San Diego!

Focus on Pediatric Transplantation:

For members interested in pediatric topics, ISHLT 2014 promises to be busy and enlightening. In a series of Thursday Pre-Meeting Symposia, you will hear experts discuss preparing pediatric patients for transition to adult care, the evolution, the biology and the limits of ABO incompatible heart transplantation, Developing a pediatric VAD program, and State of the art update on infectious diseases in pediatric thoracic transplantation. links imageAnd if you have ever wondered 'Why not infant lung transplantation?', a Sunrise Symposium during the meeting is planned just for you. And finally, a new Concurrent Symposium has been added recently to the program to address patient selection issues for pediatric thoracic transplantation.

PRE-MEETING SYMPOSIUM 6: Joint ISHLT/IPTA Symposium: Here They Come: Preparing Pediatric Patients For Transition To Adult Care (Thursday, April 12, 8:00 AM - 10:00 AM)
Transition is defined as "the process by which adolescents and young adults with chronic childhood illnesses are prepared to take charge of their lives and their health in adulthood". Effective transition programs have the potential to decrease morbidity and mortality associated with transfer of care and can improve quality of life. This session will discuss issues essential to successful transition of pediatric patients to adult care, including patient and family challenges, as well as potential strategies/interventions to meet these challenges.

PRE-MEETING SYMPOSIUM 11: Crossing Clinical Barriers on the Wings of Science: Evolution of ABO Incompatible Heart Transplantation (Thursday, April 12, 10:15 AM - 12:15 PM)
This session has multiple purposes. It is intended to show how scientific concepts are developed for clinical application. It will show the history of ABO incompatible heart transplantation, but from the point of view of the designer of therapy. In so doing, it will delineate some of the technical details in the path of a very significant advance in transplantation from idea to clinical reality. In so doing, we hope that this session will be both informative, and inspirational. We intend for this session to stimulate the thought processes necessary to take other burgeoning ideas from bench to bedside by giving a better understanding of the processes involved in translating science to our patients.

PRE-MEETING SYMPOSIUM 18: Developing A Pediatric VAD Program (Thursday, April 12, 2:00 PM - 4:00 PM)
This session offers the following objectives:

  1. To understand and review what is required to develop a VAD program at a pediatric center.
  2. To review the outcomes of children discharged home on implantable VAD support
  3. To understand important pediatric-specific medical and social obstacles impacting home VAD
  4. To discuss the future of VAD support for children.

PRE-MEETING SYMPOSIUM 23: State of the Art Update on Infectious Disease Issues in Pediatric Thoracic Transplantation (Thursday, April 12, 4:15 PM - 6:15 PM)
The infectious disease sessions at ISHLT traditionally have focused on adults rather than children. Some of the pediatric responses to infections are quite disparate from those of adults. links imageThis session will provide a state of the art update based on the latest data in pediatrics.


CONCURRENT SYMPOSIUM 30: Controversies in Listing Children for Thoracic Organ Transplant (Saturday, 4/12/2014 2:00 PM - 3:30 PM)
This recently added session will address patient selection issues for pediatric thoracic transplantation. A great group of speakers has been assembled to stimulate the conversation. We hope this conversation will be the catalyst for a consensus conference that will provide cohesive guidelines for the thoracic transplant community.

SUNRISE SYMPOSIUM 14: Why Not Infant Lung Transplantation? (Sunday, April 13, 7:00 AM - 8:00 AM)
Less than 100 infant lung transplants have been performed in the world in the last 25 years whereas over 100 infant heart and liver transplants are performed each year. This disconnect suggests that a shortage of organs does not explain this result. Chronic respiratory or cardiopulmonary failure is not rare. A recent report indicates long-term outcome is at least as good for infant lung transplant recipients as for older recipients. This session will explore the conundrum.

Share via:

links image    links image    links image    links image